CrushSCI.com
58.7平均天数
48中位天数
1最短天数
331最长天数
1822025发文量

Paper Review Records

全部论文审稿周期

29 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

25 天

Chronic Lymphocytic Leukaemia as a Disease of Time: A Four‐Clock Framework for Therapeutic Stewardship

作者
Fortunato Morabito; Enrica Antonia Martino; Ernesto Vigna; Massimo Gentile展开收起
作者单位
1. Dafne Srl Reggio Calabria Italy; 2. Hematology Unit, Department of Onco‐Hematology AO of Cosenza Cosenza Italy; 3. Department of Pharmacy, Health and Nutritional Science University of Calabria Rende Italy展开收起
PDF源文件 DOI 网页
35 天

Efficacy, Safety, and Durability of Sutimlimab in Cold Agglutinin Disease: A Systematic Review and Meta‐Analysis

作者
Jamiel Reyes; Alexander Reyes展开收起
作者单位
1. Department of Internal Medicine Universidad de Ciencias Médicas de Holguín Holguín Cuba; 2. Department of Software Engineering Universidad de Holguín Holguín Cuba展开收起
PDF源文件 DOI 网页
66 天

Comparative Prognostic Value of Mayo 2012 and European‐Modified Mayo 2004 Staging Systems in Systemic AL Amyloidosis With Discordant Risk Classification

作者
Miran Han; Jun Ho Yi; Sang Eun Yoon; Seokjin Kim; Darae Kim; Jin‐Oh Choi; Jung Eun Lee; Jung‐Sun Kim; Ju‐Hong Min; Byoung Joon Kim; Kihyun Kim展开收起
作者单位
1. Division of Hematology–Oncology, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Korea; 2. Division of Hematology–Oncology, Department of Medicine Jeonbuk National University Medical School and Hospital Jeonju South Korea; 3. Division of Cardiology, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Korea; 4. Division of Nephrology, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Korea; 5. Department of Pathology and Translational Genomics Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Korea; 6. Department of Neurology Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Korea展开收起
PDF源文件 DOI 网页
28 天

Optimizing Frontline Targeted Therapies in Chronic Lymphocytic Leukemia: An Italian Inter‐Regional Delphi Consensus on Patient Risk Stratification, Cardiovascular Safety, and Endpoint Interpretation

作者
Stefano Molica; Giacomo Loseto; Elsa Pennese; Francesco Aji; Angelo Fama; Annamaria Giordano; Giulio Giordano; Francesca Immacolata Merchionne; Rosanna Maria Miccolis; Gaetano Palumbo; Pamela Pinto; Sara Plebani; Stefania Scardino; Luana Schiattone; Antonio Giovanni Solimando; Maria Rosaria Specchia; Lorenzo Tonialini; Vincenzo Fraticelli; Potito Rosario Scalzulli; Daniela D'Angela; Stefano Oliva; Alessandro Maggi展开收起
作者单位
1. York‐Hull Medical School Hull UK; 2. UOC Ematologia, IRCCS Istituto Tumori “Giovanni Paolo II” Bari Italy; 3. UOC Ematologia Presidio Ospedaliero Pescara Pescara Italy; 4. UO Ematologia, Ospedale “Cardinale G. Panico” Tricase Italy; 5. UO Ematologia, Ospedale “Giuseppe Mazzini” Teramo Italy; 6. UO Ematologia, Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari Bari Italy; 7. UO Ematologia, Ospedale “Antonio Cardarelli” Campobasso Italy; 8. UO Ematologia, Ospedale “A. Perrino” Brindisi Italy; 9. UO Ematologia, Ospedale “Mons. R. Dimiccoli” Barletta Italy; 10. UO Ematologia, Azienda Ospedaliero Universitaria Policlinico di Foggia Foggia Italy; 11. UO Ematologia, Ospedale “F. Miulli” Acquaviva delle Fonti Italy; 12. UO Ematologia, Presidio Ospedaliero “S. Salvatore” L'Aquila Italy; 13. UO Ematologia, Ospedale “Vito Fazzi” Lecce Italy; 14. UO Ematologia, Ospedale “Santo Spirito” Pescara Italy; 15. UO Medicina Interna, Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari Bari Italy; 16. UO Ematologia, Ospedale “SS. Annunziata – Moscati” Taranto Italy; 17. UOC Ematologia, Policlinico “Gemelli” Molise Campobasso Italy; 18. UOC Ematologia, IRCCS “Casa Sollievo Della Sofferenza” San Giovanni Rotondo Italy; 19. Università Roma Tor Vergata Roma Italy; 20. UOSD Cardiologia, IRCCS Istituto Tumori “Giovanni Paolo II” Bari Italy展开收起
PDF源文件 DOI 网页
48 天

Patient‐Reported Symptom Burden and Objective Responses After Belumosudil in Heavily Pretreated Chronic GvHD

作者
Sergio Rodriguez‐Rodriguez; Jennifer White; Kylie Lepic; Nihar Desai; Brittany Salter; Mohamed Elemary; Eshrak Al‐Shaibani; Tommy Alfaro‐Moya; Arjun D. Law; Igor Novitzky‐Basso; Ivan Pasic; Auro Viswabandya; Fotios V. Michelis; Rajat Kumar; Jonas Mattsson; Dennis D. H. Kim展开收起
作者单位
1. University Health Network Princess Margaret Cancer Centre Toronto Ontario Canada; 2. University of Toronto Toronto Ontario Canada; 3. British Columbia Cancer Agency Vancouver General Hospital Vancouver British Columbia Canada; 4. University of British Columbia Vancouver British Columbia Canada; 5. Hamilton Health Sciences Juravinski Cancer Centre Hamilton Ontario Canada; 6. McMaster University Hamilton Ontario Canada; 7. Saskatchewan Cancer Agency Saskatoon Cancer Centre Saskatoon Saskatchewan Canada; 8. University of Saskatchewan Saskatoon Saskatchewan Canada展开收起
PDF源文件 DOI 网页
61 天

Efficacy and Safety of Doxorubicin–Etoposide–Methylprednisolone ( DEP )‐Based Regimens in Haemophagocytic Lymphohistiocytosis: A Systematic Review and Meta‐Analysis

作者
Mostafa Rafea; Reem Hassan; Ahmed Fayed展开收起
作者单位
1. London Northwest Healthcare NHS Trust Harrow UK; 2. London School of Hygiene and Tropical Medicine London UK; 3. Kasr Al‐Ainy School of Medicine, University of Cairo Cairo Egypt展开收起
PDF源文件 DOI 网页

FAQ

EUROPEAN JOURNAL OF HAEMATOLOGY审稿要多久?

截至2026-11-17,CrushSCI 收录了 EUROPEAN JOURNAL OF HAEMATOLOGY 的 29 篇完整审稿记录。最快一篇从收稿到录用用了 1 天(Current Challenges in Pediatric Hematology and Oncology: An Integrated Multidisciplinary Perspective,2026-05-19 收稿,2026-05-20 录用),最慢一篇用了 331 天;平均 58.7 天,中位数 48 天。最快这篇的日期间隔异常短,建议点开原文核对。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。